Changes in cholesterol kinetics following sugar cane policosanol supplementation: a randomized control trial

Amira N Kassis, Peter J H Jones, Amira N Kassis, Peter J H Jones

Abstract

Background: Sugar cane policosanols (SCP) have been shown to exert cholesterol-modulating properties in various studies conducted in Cuba by substantially reducing cholesterol synthesis. Independent research examining changes in cholesterol kinetics in response to SCP is limited to few studies, none of which was able to replicate findings of the original research. Moreover, no data are available on the effect of SCP on cholesterol absorption to date. The present study was undertaken to determine effects on cholesterol kinetics, namely synthesis and absorption, within hypercholesterolemic individuals consuming a SCP treatment. Twenty-one otherwise healthy hypercholesterolemic subjects participated in a randomized double-blind crossover study where they received 10 mg/day of policosanols or a placebo incorporated in margarine as an evening snack for a period of 28 days. The last week of the study phase, subjects were given 13C labelled cholesterol and deuterated water for the measurement of cholesterol absorption and synthesis respectively. Blood was collected on the first two and last five days of the trial. Cholesterol absorption and synthesis were determined by measuring red cell cholesterol 13C and deuterium enrichment, respectively.

Results: There was no significant change in LDL cholesterol levels as compared to control. In addition, the area under the curve for red cell cholesterol 13C enrichment across 96 hours was not significantly different in the SCP group as compared to control. Similarly, no difference was observed in the fractional rate of cholesterol synthesis over the period of 24 hours between the two treatment groups.

Conclusion: The findings of the present study fail to support previous research concerning efficacy and mechanism of action for policosanols.

Figures

Figure 1
Figure 1
13C enrichment of RBCs after isotope administration in SCP and control groups (n = 21). Black diamond: sugar cane policosanols, grey diamond: placebo. AUC SCP = 421.91; AUCcontrol = 454.55. No significant difference between the two intervention groups. n = 21.
Figure 2
Figure 2
Difference in 13C enrichment between time points and hour 0 as a result of isotope administration in SCP and control groups (n = 21). Black diamond: sugar cane policosanols, grey diamond: placebo. No significant difference between SCP and control groups. n = 21.

References

    1. Davidson MH, Robinson JG. Lipid-lowering effects of statins: a comparative review. Expert Opin Pharmacother. 2006;7:1701–1714. doi: 10.1517/14656566.7.13.1701.
    1. Jones PJ, MacDougall DE, Ntanios F, Vanstone CA. Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol. 1997;75:217–227. doi: 10.1139/cjpp-75-3-217.
    1. Kosoglou T, Statkevich P, Johnson-Levonas AO, Paolini JF, Bergman AJ, Alton KB. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet. 2005;44:467–494. doi: 10.2165/00003088-200544050-00002.
    1. Menendez R, Amor AM, Gonzalez RM, Fraga V, Mas R. Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats. Biol Res. 1996;29:253–257.
    1. Menendez R, Fernandez SI, Del Rio A, Gonzalez RM, Fraga V, Amor AM, Mas RM. Policosanol inhibits cholesterol biosynthesis and enhances low density lipoprotein processing in cultured human fibroblasts. Biol Res. 1994;27:199–203.
    1. Menendez R, Arruzazabala L, Mas R, Del Rio A, Amor AM, Gonzalez RM, Carbajal D, Fraga V, Molina V, Illnait J. Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet. Br J Nutr. 1997;77:923–932. doi: 10.1079/BJN19970090.
    1. Fernandez J, Mas R, Castano G, Menendez R, Amor A, Gonzalez R, Alvarez E. Comparison of the efficacy, safety and tolerability of policosanol versus Fluvastatin in elderly hypercholesterolemic women. Clin Drug Invest. 2001;21:103–113. doi: 10.2165/00044011-200121020-00003.
    1. Basu SK, Goldstein JL, Anderson GW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 1976;73:3178–3182. doi: 10.1073/pnas.73.9.3178.
    1. Junker LH, Davis RA. Receptor-mediated uptake of low density lipoprotein stimulates bile acid synthesis by cultured rat hepatocytes. J Lipid Res. 1989;30:1933–1941.
    1. Singh DK, Li L, Porter TD. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. J Pharmacol Exp Ther. 2006;318:1020–1026. doi: 10.1124/jpet.106.107144.
    1. Wang YW, Jones PJ, Pischel I, Fairow C. Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters. Lipids. 2003;38:165–170. doi: 10.1007/s11745-003-1047-3.
    1. Marinangeli CP, Kassis AN, Jain D, Ebine N, Cunnane SC, Jones PJ. Comparison of composition and absorption of sugarcane policosanols. Br J Nutr. 2007;97:381–388. doi: 10.1017/S0007114507336763.
    1. Wang Y, Vanstone CA, Parsons WD, Jones PJ. Validation of a single-isotope-labeled cholesterol tracer approach for measuring human cholesterol absorption. Lipids. 2004;39:87–91. doi: 10.1007/s11745-004-1206-6.
    1. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509.
    1. Kassis AN, Jones PJ. Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons. Am J Clin Nutr. 2006;84:1003–1008.
    1. Menendez R, Mas R, Amor AM, Rodeiros I, Gonzalez RM, Alfonso JL. Inhibition of cholesterol biosynthesis in cultured fibroblasts by D003, a mixture of very long chain saturated fatty acids. Pharmacol Res. 2001;44:299–304. doi: 10.1006/phrs.2001.0851.
    1. Menendez R, Amor AM, Rodeiro I, Gonzalez RM, Gonzalez PC, Alfonso JL, Mas R. Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts. Arch Med Res. 2001;32:8–12. doi: 10.1016/S0188-4409(00)00265-4.
    1. Wang Y, Ebine N, Jia X, Jones PJ, Fairow C, Jaeger R. Very long chain fatty acids (policosanols) and phytosterols affect plasma lipid levels and cholesterol biosynthesis in hamsters. Metabolism. 2005;54:508–514. doi: 10.1016/j.metabol.2004.11.004.
    1. Menendez R, Marrero D, Mas R, Fernandez I, Gonzalez L, Gonzalez RM. In vitro and in vivo study of octacosanol metabolism. Arch Med Res. 2005;36:113–119. doi: 10.1016/j.arcmed.2004.12.006.
    1. Jones PJ, Scanu AM, Schoeller DA. Plasma cholesterol synthesis using deuterated water in humans: effect of short-term food restriction. J Lab Clin Med. 1988;111:627–633.
    1. Jones PJ. Use of deuterated water for measurement of short-term cholesterol synthesis in humans. Can J Physiol Pharmacol. 1990;68:955–959.
    1. Jones PJ, Leitch CA, Li ZC, Connor WE. Human cholesterol synthesis measurement using deuterated water. Theoretical and procedural considerations. Arterioscler Thromb. 1993;13:247–253.
    1. Leitch CA, Jones PJ. Measurement of human lipogenesis using deuterium incorporation. J Lipid Res. 1993;34:157–163.
    1. Castano G, Menendez R, Mas R, Amor A, Fernandez JL, Gonzalez RL, Lezcay M, Alvarez E. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus. Int J Clin Pharmacol Res. 2002;22:89–99.
    1. Castano G, Fernandez L, Mas R, Illnait J, Mesa M, Fernandez JC. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus. Clin Drug Investig. 2003;23:639–650. doi: 10.2165/00044011-200323100-00003.
    1. Castano G, Mas R, Gamez R, Fernandez L, Illnait J. Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study. Angiology. 2004;55:361–371. doi: 10.1177/000331970405500403.
    1. Parker TS, McNamara DJ, Brown C, Garrigan O, Kolb R, Batwin H, Ahrens EH., Jr Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man. Proceedings of the National Academy of Sciences of the United States of America. 1982;79:3037–3041. doi: 10.1073/pnas.79.9.3037.
    1. Cella LK, Van Cauter E, Schoeller DA. Diurnal rhythmicity of human cholesterol synthesis: normal pattern and adaptation to simulated "jet lag". The American journal of physiology. 1995;269:E489–498.
    1. Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia. A randomized controlled trial. JAMA. 2006;295:2263–2269. doi: 10.1001/jama.295.19.2262.
    1. Greyling A, De Witt C, Oosthuizen W, Jerling JC. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects. Br J Nutr. 2006;95:968–975. doi: 10.1079/BJN20061715.
    1. Lin Y, Rudrum M, Wielen RP van der, Trautwein EA, McNeill G, Sierksma A, Meijer GW. Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations. Metabolism. 2004;53:1309–1314. doi: 10.1016/j.metabol.2004.05.006.
    1. Dulin MF, Hatcher LF, Sasser HC, Barringer TA. Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial. Am J Clin Nutr. 2006;84:1543–1548.
    1. Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial. Am Heart J. 2006;152:e981–985. doi: 10.1016/j.ahj.2006.08.009.
    1. Law MR. Plant sterol and stanol margarines and health. West J Med. 2000;173:43–47. doi: 10.1136/ewjm.173.1.43.
    1. Castano G, Fernandez L, Mas R, Illnait J, Fernandez J, Mesa M, Alvarez E, Lezcay M. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia. Int J Clin Pharmacol Res. 2002;22:55–66.
    1. Castano G, Fernandez L, Mas R, Illnait J, Mesa M, Fernandez J. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidemia and type 2 diabetes mellitus. Clin Drug Invest. 2003;23:639–650. doi: 10.2165/00044011-200323100-00003.
    1. Fernandez J, Mas R, Castano G, Menendez R, Amor A, Gonzalez R, Alvarez E. Comparison of the efficacy, safety and tolerability of policosanol versus Fluvastatin in elderly hypercholesterolemic women. Clin Drug Invest. 2001;21:103–113. doi: 10.2165/00044011-200121020-00003.
    1. Mas R, Castano G, Illnait J, Fernandez L, Fernandez J, Aleman C, Pontigas V, Lescay M. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clin Pharmacol Ther. 1999;65:439–447. doi: 10.1016/S0009-9236(99)70139-6.
    1. Raeini-Sarjaz M, Vanstone CA, Papamandjaris AA, Wykes LJ, Jones PJ. Comparison of the effect of dietary fat restriction with that of energy restriction on human lipid metabolism. Am J Clin Nutr. 2001;73:262–267.
    1. Di Buono M, Hannah JS, Katzel LI, Jones PJ. Weight loss due to energy restriction suppresses cholesterol biosynthesis in overweight, mildly hypercholesterolemic men. J Nutr. 1999;129:1545–1548.
    1. Santosa S, Demonty I, Lichtenstein AH, Jones PJ. Cholesterol metabolism and body composition in women: the effects of moderate weight loss. Int J Obes (Lond) 2007;31:933–941. doi: 10.1038/sj.ijo.0803549.
    1. Simonen P, Gylling H, Howard AN, Miettinen TA. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr. 2000;72:82–88.
    1. Simonen P, Gylling H, Miettinen TA. Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes. Clin Chim Acta. 2002;316:55–61. doi: 10.1016/S0009-8981(01)00734-3.
    1. Jolliffe N. Dietary factors regulating serum cholesterol. Metabolism. 1961;10:497–513.
    1. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res. 1990;31:1149–1172.
    1. Salter AM, White DA. Effects of dietary fat on cholesterol metabolism: regulation of plasma LDL concentration. Nutrition Research Reviews. 1996;9:241–257. doi: 10.1079/NRR19960013.
    1. Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial. Am Heart J. 2006;152:982–e-915. doi: 10.1016/j.ahj.2006.08.009.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe